Third-Degree Atrioventricular Block Workup

  • Author: Adam S Budzikowski, MD, PhD; Chief Editor: Jeffrey N Rottman, MD   more...
 
Updated: Sep 16, 2011
 

Laboratory Studies

For most patients with illness serious enough to cause third-degree atrioventricular (AV) block (ie, complete heart block), a complete blood count (CBC) is indicated to screen for coincident problems (eg, anemia, infection) that may require emergency intervention. The presence of fever or an elevated white blood cell (WBC) count should be evaluated by using blood cultures because endocarditis can be complicated by heart block.

Serum concentrations of electrolytes, including potassium and magnesium, should be measured to look for metabolic imbalance, indications of renal insufficiency or failure, and particularly for severe hyperkalemia. The prothrombin time and activated partial thromboplastin time should also be routinely obtained.

A digoxin level should be obtained for patients on digoxin or in whom ingestion of digoxinlike compounds (eg, Lily of the Valley, Oleander, Foxglove, Bufonidae toads) is suspected. The same should be done for any other drugs the patient is taking that are capable of causing AV block. Note that the presence of a detectable digoxin level following a nondigoxin cardiac glycoside ingestion can only confirm the presence of such a toxin. The digoxin level does not correlate to the degree of cardiac glycoside toxicity following nondigoxin-induced cardiac glycoside ingestions.

Myocarditis-related laboratory studies should be performed in patients suspected of having myocarditis. Such studies include Lyme titers, HIV serologies, enterovirus polymerase chain reaction (PCR), adenovirus PCR, and Chagas titers, as clinically appropriate.

Lyme titers should be obtained from all patients who may have been exposed to Lyme disease. Because cardiac manifestations of Lyme disease are delayed, Lyme-induced heart block can occur during any season. The decision to perform serologic testing for Lyme disease or any of the collagen vascular diseases depends on other associated history and findings.

Next

Imaging Studies

A chest radiograph should be obtained.

If examination findings or history suggest cardiomyopathy or valvular disease, then transthoracic echocardiography should be performed. Specific etiologies (eg, valve ring abscess) may call for transesophageal echo imaging. A determination of left ventricular function by means of echocardiography or another technique can help in determining whether a pacemaker or defibrillator should be implanted for the treatment of the heart block.

Previous
Next

Electrocardiography

The most important study is 12-lead electrocardiography (ECG). On 12-lead ECG, third-degree AV block is characterized by complete lack of conduction (no P waves cause a QRS complex). If complete AV block exists, then the R-R interval is very regular; therefore, before diagnosing third-degree AV block, the R-R interval should be either marched out or measured. If high-grade AV block exists without complete heart block, then some irregularity may occur during intervals following conducted P waves.

Various pathologic conditions can cause conduction system disease and heart block (see Etiology). These systemic or myocardial diseases rarely present as conduction block, with the exception of Lyme disease, inferior myocardial infarction (MI), and some of the neuromuscular diseases. Unless suggested by history, examination findings, family history, risk factors, or 12-lead ECG findings, the authors do not screen for underlying pathology.

Surface ECG and review of prior ECG data can provide important clues to the level of third-degree AV block. The assessment can begin with a review of the current QRS width and morphology, comparing the QRS during heart block to the QRS when conduction was occurring (see the image below).

ECG before and after complete heart block at the AECG before and after complete heart block at the AV nodal level.

If the QRS is narrow (< 120 msec) during conducted beats and narrow with the same morphology during escape beats, then the block is in the AV junction. If the conducted QRS was narrow at baseline and is wide during the escape rhythm (see the image below), then this is likely a distal level of block located anatomically in the His bundle or in both right and left bundles.

Complete heart block with wide complex escape. Complete heart block with wide complex escape.
Previous
Next

Other Studies

If history or 12-lead ECG findings suggest active coronary artery disease, then cardiac enzyme levels measurements and an evaluation of ischemia, including either cardiac catheterization or stress testing, are needed.

Ambulatory monitoring may be performed to document heart-transient heart block or other bradyarrhythmias in patients presenting with symptoms suggestive of bradycardia.

Diagnostic electrophysiologic studies can be performed to assess AV conduction and to discern the level of block (AV nodal or infranodal) when necessary.

Previous
 
 
Contributor Information and Disclosures
Author

Adam S Budzikowski, MD, PhD  Assistant Professor of Medicine, Division of Cardiovascular Medicine, Electrophysiology Section, State University of New York Downstate Medical Center, University Hospital of Brooklyn

Adam S Budzikowski, MD, PhD is a member of the following medical societies: European Society of Cardiology, Heart Rhythm Society, and Polish Society of Cardiology

Disclosure: Boston Scientific Consulting fee Consulting; St. Jude Medical Honoraria Speaking and teaching; Zoll Honoraria Speaking and teaching

Coauthor(s)

Andrew C Corsello, MD  Consulting Staff, Department of Internal Medicine, Division of Cardiology, Cardiovascular Consultants of Maine, PA

Disclosure: Nothing to disclose.

James P Daubert, MD  Professor of Medicine, Cardiology Division, Duke University School of Medicine

James P Daubert, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, and Heart Rhythm Society

Disclosure: Medtronic Equity interest None; Boston Scientific Honoraria Speaking and teaching; CV Therapeutics Consulting fee Consulting; Cryocor Consulting fee Consulting

Theodore J Gaeta, DO, MPH, FACEP  Clinical Associate Professor, Department of Emergency Medicine, Weill Cornell Medical College; Vice Chairman and Program Director of Emergency Medicine Residency Program, Department of Emergency Medicine, New York Methodist Hospital; Academic Chair, Adjunct Professor, Department of Emergency Medicine, St George's University School of Medicine

Theodore J Gaeta, DO, MPH, FACEP is a member of the following medical societies: Alliance for Clinical Education, American College of Emergency Physicians, Clerkship Directors in Emergency Medicine, Council of Emergency Medicine Residency Directors, New York Academy of Medicine, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Michael D Levine, MD  Physician, Department of Medical Toxicology, Banner Good Samaritan Medical Center; Physician, Department of Emergency Medicine, Banner Thunderbird Medical Center

Michael D Levine, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, American College of Medical Toxicology, American Medical Association, Emergency Medicine Residents Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Abrar H Shah, MD  Clinical Assistant Professor, Department of Medicine, University of Rochester Medical Center; Consulting Staff, Department of Medicine (Cardiology), Strong Memorial Hospital, Geneva General Hospital; Consulting Staff, Department of Cardiology, Highland Hospital; Consulting Staff, Department of Cardiology and Electrophysiology, Park Ridge Hospital

Disclosure: Nothing to disclose.

Specialty Editor Board

Eddy S Lang, MDCM, CCFP(EM), CSPQ  Associate Professor, Senior Researcher, Division of Emergency Medicine, Department of Family Medicine, University of Calgary Faculty of Medicine; Assistant Professor, Department of Family Medicine, McGill University Faculty of Medicine, Canada

Eddy S Lang, MDCM, CCFP(EM), CSPQ is a member of the following medical societies: American College of Emergency Physicians, Canadian Association of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Brian Olshansky, MD  Professor of Medicine, Department of Internal Medicine, University of Iowa College of Medicine

Brian Olshansky, MD is a member of the following medical societies: American Autonomic Society, American College of Cardiology, American College of Chest Physicians, American College of Physicians, American College of Sports Medicine, American Federation for Clinical Research, American Heart Association, Cardiac Electrophysiology Society, Heart Rhythm Society, and New York Academy of Sciences

Disclosure: Guidant/Boston Scientific Honoraria Speaking and teaching; Medtronic Honoraria Speaking and teaching; Guidant/Boston Scientific Consulting fee Consulting; Novartis Honoraria Speaking and teaching; Novartis Consulting fee Consulting

David FM Brown, MD  Associate Professor, Division of Emergency Medicine, Harvard Medical School; Vice Chair, Department of Emergency Medicine, Massachusetts General Hospital

David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Jeffrey N Rottman, MD  Professor of Medicine and Pharmacology, Vanderbilt University School of Medicine; Chief, Department of Cardiology, Nashville Veterans Affairs Medical Center

Jeffrey N Rottman, MD is a member of the following medical societies: American Heart Association and North American Society of Pacing and Electrophysiology (NASPE)

Disclosure: Nothing to disclose.

References
  1. Narula OS, Scherlag BJ, Javier RP, Hildner FJ, Samet P. Analysis of the A-V conduction defect in complete heart block utilizing His bundle electrograms. Circulation. Mar 1970;41(3):437-48. [Medline].

  2. Rosen KM, Dhingra RC, Loeb HS, Rahimtoola SH. Chronic heart block in adults. Clinical and electrophysiological observations. Arch Intern Med. May 1973;131(5):663-72. [Medline].

  3. Costedoat-Chalumeau N, Georgin-Lavialle S, Amoura Z, Piette JC. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus. 2005;14(9):660-4. [Medline].

  4. Finsterer J, Stöllberger C, Steger C, Cozzarini W. Complete heart block associated with noncompaction, nail-patella syndrome, and mitochondrial myopathy. J Electrocardiol. Oct 2007;40:352-4. [Medline]. [Full Text].

  5. Bestetti RB, Cury PM, Theodoropoulos TA, Villafanha D. Trypanosoma cruzi myocardial infection reactivation presenting as complete atrioventricular block in a Chagas' heart transplant recipient. Cardiovasc Pathol. Nov-Dec 2004;13(6):323-6. [Medline].

  6. Ma TS, Collins TC, Habib G, Bredikis A, Carabello BA. Herpes zoster and its cardiovascular complications in the elderly--another look at a dormant virus. Cardiology. 2007;107:63-7. [Medline]. [Full Text].

  7. Abuin G, Nieponice A, Barcelo A, Rojas-Granados A, Leu PH, Arteaga-Martinez M. Anatomical reasons for the discrepancies in atrioventricular block after inferior myocardial infarction with and without right ventricular involvement. Tex Heart Inst J. 2009;36(1):8-11. [Medline].

  8. Nguyen HL, Lessard D, Spencer FA, Yarzebski J, Zevallos JC, Gore JM. Thirty-year trends (1975-2005) in the magnitude and hospital death rates associated with complete heart block in patients with acute myocardial infarction: a population-based perspective. Am Heart J. Aug 2008;156(2):227-33. [Medline].

  9. Merin O, Ilan M, Oren A, Fink D, Deeb M, Bitran D. Permanent pacemaker implantation following cardiac surgery: indications and long-term follow-up. Pacing Clin Electrophysiol. Jan 2009;32(1):7-12. [Medline].

  10. Kojic EM, Hardarson T, Sigfusson N, Sigvaldason H. The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik study. J Intern Med. Jul 1999;246(1):81-6. [Medline].

  11. [Guideline] Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm. Jun 2008;5(6):934-55. [Medline].

  12. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Part III. Adult advanced cardiac life support. JAMA. Oct 28 1992;268(16):2199-241. [Medline].

  13. International Liaison Committee on Resuscitation. 2005 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Part 4: Advanced life support. Resuscitation. Nov-Dec 2005;67(2-3):213-47. [Medline].

  14. Syverud S. Cardiac pacing. Emerg Med Clin North Am. May 1988;6(2):197-215. [Medline].

Previous
Next
 
ECG before and after complete heart block at the AV nodal level.
Complete heart block with wide complex escape.
Electrocardiogram from patient in complete heart block.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.